Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer
Genitourinary Cancer
Related content
Genitourinary Cancer
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial
★ 2
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Machado A, Levental M, Ghai S, Chang S, Milot L, Patel C, Kassam Z, Moore C, Kasivisanathan V, Loblaw A, Kebabdjian M, Earle CC, Pond GR, Haider MA
doi: 10.1001/jamaoncol.2020.7589
Genitourinary Cancer
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability
JAMA Oncol.
Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW
doi: 10.1001/jamaoncol.2020.3187.
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification
JAMA Oncol.
Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, Nix JW, Thomas JV, Gordetsky JB, Gaur S, Harmon SA, Siddiqui MM, Merino MJ, Parnes HL, Wood BJ, Pinto PA, Choyke PL, Turkbey B
doi: 10.1001/jamaoncol.
Genitourinary Cancer
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study
Lancet Oncol.
Klemann N, Røder MA, Helgstrand JT, Brasso K, Toft BG, Vainer B, Iversen P
doi: 10.1016/
Genitourinary Cancer
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Lancet Oncol.
Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group
doi: 10.1016/
Genitourinary Cancer
Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
Eur J Radiol.
Stanzione A, Imbriaco M, Cocozza S, Fusco F, Rusconi G, Nappi C, Mirone V, Mangiapia F, Brunetti A, Ragozzino A, Longo N
doi: 10.1016/j.ejrad.2016.10.009
Genitourinary Cancer
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies
Eur Urol.
Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A
doi: 10.1016/j.eururo.2018.10.012.
Genitourinary Cancer
Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients
Eur Urol.
Rischmann P, Gelet A, Riche B, Villers A, Pasticier G, Bondil P, Jung JL, Bugel H, Petit J, Toledano H, Mallick S, Rouvière O, Rabilloud M, Tonoli-Catez H, Crouzet S
doi: 10.1016/
Genitourinary Cancer
Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project.
BJU Int.
Hurle R, Pasini L, Lazzeri M, Colombo P, Buffi N, Lughezzani G, Casale P, Morenghi E, Peschechera R, Zandegiacomo S, Benetti A, Saita A, Cardone P, Guazzoni G
doi: 10.1111/bju.13536